HomeXRTX • CVE
add
XORTX Therapeutics Inc
Previous close
$0.49
Day range
$0.56 - $0.56
Year range
$0.49 - $1.97
Market cap
3.87M CAD
Avg Volume
3.03K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 579.09K | 27.41% |
Net income | -590.46K | -581.87% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -491.23K | -10.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 864.51K | -65.05% |
Total assets | 2.68M | -34.46% |
Total liabilities | 599.07K | -20.97% |
Total equity | 2.08M | — |
Shares outstanding | 6.54M | — |
Price to book | 1.52 | — |
Return on assets | -52.70% | — |
Return on capital | -69.69% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -590.46K | -581.87% |
Cash from operations | -701.86K | 20.82% |
Cash from investing | -264.26K | -6,447.50% |
Cash from financing | 632.53K | -42.86% |
Net change in cash | -329.40K | -290.51% |
Free cash flow | -802.77K | 37.38% |
About
Founded
2011
Headquarters
Website
Employees
3
